Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;43(4):1437-1449.
doi: 10.1007/s10792-022-02537-6. Epub 2022 Oct 22.

Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review

Xueting Li  1 , Senmao Li  1 , Wanlin Fan  1 , Alexander C Rokohl  1   2 , Sitong Ju  1 , Xiaojun Ju  1 , Yongwei Guo  3   4 , Ludwig M Heindl  5   6
Affiliations
Review

Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review

Xueting Li et al. Int Ophthalmol. 2023 Apr.

Abstract

Graves ophthalmopathy (GO), which occurs in autoimmune thyroid disease, can reduce patients' quality of life due to its impact on visual function, physical appearance, and emotional health. Corticosteroids have been the first-line treatment for GO. More recently, the pathogenesis of GO has made significant progress. Various targeting biological agents and immunosuppressive agents make GO management more promising. Fully understanding GO pathogenesis and precise clinical management are beneficial for the prognosis of patients. Therefore, we conducted a comprehensive review of the medical management of GO and summarized research developments to highlight future research issues.

Keywords: Diagnosis; Graves ophthalmopathy; Management; Thyroid-associated ophthalmopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interests.

Figures

Fig. 1
Fig. 1
Graves Ophthalmopathy pathogenesis. Autoreactive T cells interact with orbital fibroblasts (OFs) via CD40:CD154 ligation. B cells differentiate into plasma cells, which synthesize and secrete TRAb. TRAb can mediate the autoimmune response of GO by recognizing TSHR. Activated OFs then secrete various inflammatory cytokines. TSHR and IGF-1R are expressed in the common area of the OFs membrane and exist in the form of a complex which plays a synergistic role in the functional regulation of orbital fibroblasts. Activated OFs can differentiate into either myofibroblasts or adipocytes and promote hyaluronan synthesis. As a result, orbital soft tissue expansion and congestion in GO. Created with BioRender.com
See this image and copyright information in PMC

References

    1. Ponto KA, et al. Prevalence, Phenotype, and Psychosocial WellBeing in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy. Thyroid. 2015;5(8):942–948. doi: 10.1089/thy.2015.0031. - DOI - PubMed
    1. Perros P, et al. Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis. 2017;12(1):72. doi: 10.1186/s13023-017-0625-1. - DOI - PMC - PubMed
    1. Piantanida E, et al. Prevalence and natural history of Graves’ orbitopathy in the XXI century. J Endocrinol Invest. 2013;36(6):444–449. doi: 10.3275/8937. - DOI - PubMed
    1. Smith TJ, Hegedüs L. Graves’ Disease. N Engl J Med. 2016;375(16):1552–1565. doi: 10.1056/NEJMra1510030. - DOI - PubMed
    1. Ponto KA, et al. Public health relevance of Graves’ orbitopathy. J Clin Endocrinol Metab. 2013;98(1):145–152. doi: 10.1210/jc.2012-3119. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources